NCT05602792: A Study of T3011 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumors |
|
|
| Recruiting | 1/2 | 233 | RoW | T3011 | ImmVira Pharma Co. Ltd | Advanced Solid Tumor, Sarcoma, HNSCC, Breast Cancer, Esophagus Cancer, NSCLC, Non-melanoma Skin Cancer | 07/23 | 01/24 | | |
NCT04370587: A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors |
|
|
| Recruiting | 1/2 | 64 | US, RoW | T3011, T3011 + pembrolizumab | ImmVira Pharma Co. Ltd | Solid Tumor, Melanoma, HNSCC, Sarcoma, Squamous Cell Carcinoma, NSCLC | 10/23 | 10/25 | | |
